These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2204867)

  • 1. [The Szontágh IUD and cervix carcinoma (results of a 10-year follow up study)].
    Batár I
    Orv Hetil; 1990 Aug; 131(34):1871-4. PubMed ID: 2204867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term cytologic studies of copper-IUD users.
    Engineer AD; Misra JS; Tandon P
    Acta Cytol; 1981; 25(5):550-6. PubMed ID: 6945020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-malignant and malignant cervical pathologies among inert and copper-bearing intrauterine contraceptive device users: a 10-year follow-up study.
    Ganacharya S; Bhattoa HP; Batár I
    Eur J Contracept Reprod Health Care; 2006 Jun; 11(2):89-97. PubMed ID: 16854681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytologic and histologic findings in women using an IUD.
    Risse EK; Beerthuizen RJ; Vooijs GP
    Obstet Gynecol; 1981 Nov; 58(5):569-73. PubMed ID: 7301231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative changes of exocervical exfoliative cytology in intrauterine device users].
    Mossa B; Polli R; Lo Preiato A
    Minerva Ginecol; 1986; 38(1-2):81-4. PubMed ID: 3960380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cytology associated with levonorgestrel contraception.
    Misra JS; Engineer AD; Tandon P
    Acta Cytol; 1995; 39(1):45-9. PubMed ID: 7847008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age.
    Bahamondes L; Faundes A; Sobreira-Lima B; Lui-Filho JF; Pecci P; Matera S
    Contraception; 2005 Nov; 72(5):337-41. PubMed ID: 16246658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does the IUD influence subsequent fertility?
    Batár I
    Acta Med Hung; 1986; 43(2):109-22. PubMed ID: 3588155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term use of intrauterine devices.
    Novak MK; Andolsek L; Balogh SA; Waszak CS
    IPPF Med Bull; 1988 Feb; 22(1):1-3. PubMed ID: 12281431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with intrauterine contraceptive devices (IUDs) inserted with and without tail.
    Batár I; Lampé LG; Allonen H
    Acta Chir Hung; 1988; 29(4):385-93. PubMed ID: 3239338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Presentation of a new IUD: the "Ombrelle 250"].
    Audebert AJ; Emperaire JC; Larue-charlus S
    Contracept Fertil Sex (Paris); 1985 Sep; 13(9):967-71. PubMed ID: 12267500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health risks in intrauterine contraception].
    Randić L; Haller H
    Jugosl Ginekol Perinatol; 1989; 29(5-6):181-6. PubMed ID: 2640266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actinomyces in cervical smears of women using intrauterine contraceptive devices.
    Mali B; Joshi JV; Wagle U; Hazari K; Shah R; Chadha U; Gokral J; Bhave G
    Acta Cytol; 1986; 30(4):367-71. PubMed ID: 3526779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of cervical neoplasia and infection in women using intrauterine contraceptive devices.
    Blenkinsopp WK; Chapman P
    J Reprod Med; 1982 Nov; 27(11):709-13. PubMed ID: 7153984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiologic study of cervico-vaginal pathology in IUD users].
    Mossa B; Marziani R; Galeano C; Magnanti G; Domenici R
    Minerva Ginecol; 1993; 45(1-2):27-30. PubMed ID: 8469361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of long-term use of intrauterine devices.
    Hata Y; Ishihama A; Kudo N; Nakamura Y; Miyai T; Makino T; Kagabu T
    Int J Fertil; 1969; 14(3):241-9. PubMed ID: 5812146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medicated stainless steel ring-165, medicated gamma-intrauterine devices and TCu220C: a multicenter comparative study].
    Zhuang L; Yang B; Yuan H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Feb; 32(2):97-101. PubMed ID: 9596880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.